Physical Sciences and Mathematics | Open Access Articles

Mgrre_Thinsections_Mgrre-82_18, Mgrre

Thin Sections

No abstract provided.

Go to article

Mgrre_Thinsections_Mgrre-82_19, Mgrre

Thin Sections

No abstract provided.

Go to article

On Assessing Survival Benefit Of Immunotherapy Using Long-Term Restricted Mean Survival Time, Miki Horiguchi, Lu Tian, Hajime Uno

Harvard University Biostatistics Working Paper Series

The pattern of the difference between two survival curves we often observe in randomized clinical trials for evaluating immunotherapy is not proportional hazards; the treatment effect typically appears several months after the initiation of the treatment (i.e., delayed difference pattern). The commonly used logrank test and hazard ratio estimation approach will be suboptimal concerning testing and estimation for those trials. The long-term restricted mean survival time (LT-RMST) approach is a promising alternative for detecting the treatment effect that potentially appears later in the study. A challenge in employing the LT-RMST approach is that it must specify a lower end of …

Go to article